Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020

Abstract

As treatment options expand in NSCLC in China, physicians face complex decisions for the treatment of their patients. Treatment patterns often vary, including by disease histology and clinically relevant biomarkers. The standard of care for NSCLC in China also differs from the USA.